Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe

BACKGROUND: Statins are frequently administered to reduce low-density lipoprotein cholesterol (LDL-C) and vascular inflammation, because LDL-C and high sensitive C-reactive protein (hs-CRP) are associated with high risk for cardiovascular events. When statins do not reduce LDL-C to desired levels in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Yamazaki, Daisuke, Ishida, Masaru, Watanabe, Hiroyuki, Nobori, Kiyoshi, Oguma, Yasunori, Terata, Yutaka, Koyama, Takashi, Iino, Kenji, Kosaka, Toshimitsu, Ito, Hiroshi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3598241/
https://ncbi.nlm.nih.gov/pubmed/23374898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-511X-12-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak